Director’s meeting of the Company No. 5/2019 held on July 10, 2019, has approved the Company to acquire additional 7,499,998 common shares of WPS (Thailand) Co., Ltd. (“WPS”) from the existing shareholders at
across sectors and geography due to (1) a severe outbreak of the current third wave starting since the end of March 2021 which could induce the government to enforce additional partial lockdown measures
increasing from 15,000 tons per month before acquisition. With increased market share and improvement in quality, further increase in capacity utilization to 70% was planned by March 2020. Due to COVID-19
, 2019, the Company has cost of services at Baht 114.25 million which increased compared to the same quarter of prior year by Baht 14.25 million or equivalent to 14.31% mainly due to increasing dentist
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
, and the processes and procedures shall be improved in line with the policy which has been changed. Additional Guidelines 1. The policy on the management of information technology risk under Clause 5(1
year mainly due production disruptions during 1st Quarter 2019 combined with the negative HRC cash margin for second half of 2019 resulting from large decrease in HRC selling price compared to last year
, private consumption and tourism. Both private and public investments remain largely at stable levels whilst consumer spending is constrained due to high household debt levels, decline in agricultural
the past year, which required additional debt financing, leading to higher interest expense. Reported share of loss from associates/JVs was THB 23mn, largely due to a share of loss THB 30mn from Sansiri